Corrigendum to “Distinct Disease-Modifying Therapies Are Associated with Different Blood Immune Cell Profiles in People with Relapsing-Remitting Multiple Sclerosis” [Int. Immunopharmacol. 131 (2024) 111826] (International Immunopharmacology (2024) 131, (S1567576924003448), (10.1016/J.intimp.2024.111826))